Zhejiang University

This study tests whether giving two drugs—blinatumomab and venetoclax—after a stem cell transplant can help prevent relapse in adults with high-risk B-cell acute lymphoblastic leukemia (B-ALL). About 24 participants aged 14-65 will receive this maintenance therapy. The main goal …

This early-phase study tests a new cell therapy (NW-301VT) in 9 adults with advanced solid tumors that have a specific KRAS mutation and HLA type. The treatment uses the patient's own immune cells, modified to better recognize and attack cancer while resisting tumor-suppressing s…

This early-phase study tests a new treatment called ACT#001 CAR-T cells for men with castration-resistant prostate cancer (CRPC) that has not responded to standard hormone therapy. The treatment is injected directly into the tumor area. The main goal is to check safety, and resea…

This early-phase study tests a new cell therapy called CT0180 in 21 adults with advanced liver cancer that has not responded to other treatments. The main goals are to check safety, find the best dose, and see how long the cells stay in the body. Participants receive one or more …

This study uses CT scans from 10,000 liver tumor patients to train an AI model that outlines tumors in 3D. Doctors then check and improve the AI's work. The goal is to create a better tool for early liver cancer screening, catching the disease sooner when treatment may work bette…

This study tests an artificial intelligence model called PANDAPro that helps doctors spot pancreatic cancer on regular CT scans. Researchers will compare how well the AI finds cancers versus standard reading, and see if it catches tumors that were missed. The goal is to make scre…